Status:

COMPLETED

Long-term Corticosteroid Use and Lifestyle Advices: A Qualitative Analysis of the Difficulties Encountered by Patients

Lead Sponsor:

University Hospital, Montpellier

Conditions:

Patients Traited by Long Term Corticotherapy

Eligibility:

All Genders

18+ years

Brief Summary

Introduction: Nearly 1% of the population is currently treated with long-term corticosteroid therapy. When corticosteroids are introduced, patient information concerning the adverse effects and the mo...

Detailed Description

Prospective Qualitative Study Carried out among patients followed in rheumatology and in general medical practice. For each voluntary patient, a semi-directed interview was carried out in a consultat...

Eligibility Criteria

Inclusion

  • adult patients taking corticosteroids at an average dose ≥ 5 mg/day of equivalent prednisone over a period ≥ 3 months.

Exclusion

  • major memory impairment or language barrier.

Key Trial Info

Start Date :

April 1 2015

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2015

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT03324750

Start Date

April 1 2015

End Date

August 1 2015

Last Update

July 19 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU Lapeyronie

Montpellier, France, 34000